{"name": "Avila Therapeutics", "permalink": "avila-therapeutics", "crunchbase_url": "http://www.crunchbase.com/company/avila-therapeutics", "homepage_url": "http://www.avilatx.com", "blog_url": "", "blog_feed_url": "", "twitter_username": "", "category_code": "biotech", "number_of_employees": null, "founded_year": null, "founded_month": null, "founded_day": null, "deadpooled_year": null, "deadpooled_month": null, "deadpooled_day": null, "deadpooled_url": null, "tag_list": "", "alias_list": "", "email_address": "info@avilatx.com", "phone_number": "781-891-0086", "description": "", "created_at": "Tue Jul 12 03:16:01 UTC 2011", "updated_at": "Fri Jan 27 03:45:23 UTC 2012", "overview": "\u003Cp\u003EAvila Therapeutics is a clinical-stage biotechnology company focused on the design and development of targeted covalent drugs to achieve best-in class outcomes. This approach, called \u00e2\u20ac\u0153protein silencing\u00e2\u20ac\u009d, cannot be achieved through traditional chemistry techniques. The company\u00e2\u20ac\u2122s product pipeline has been built using  its proprietary Avilomics\u00e2\u201e\u00a2 platform and is currently focused on cancer, viral infection and autoimmune disease. Avila\u00e2\u20ac\u2122s most advanced product candidate, AVL-292, a potential treatment for cancer and autoimmune diseases, is currently in Phase 1 clinical testing. Avila is funded by leading venture capital firms: Abingworth, \nAdvent Venture Partners, Atlas Venture, Novartis Option Fund, and Polaris Venture Partners.\u003C/p\u003E", "image":  {"available_sizes":    [[[110,       93],      "assets/images/resized/0014/3663/143663v1-max-150x150.jpg"],     [[110,       93],      "assets/images/resized/0014/3663/143663v1-max-250x250.jpg"],     [[110,       93],      "assets/images/resized/0014/3663/143663v1-max-450x450.jpg"]],   "attribution": null}, "products":  [], "relationships":  [{"is_past": false,    "title": "Chief Executive Officer",    "person":     {"first_name": "Katrine",      "last_name": "Bosley",      "permalink": "katrine-bosley"}},   {"is_past": false,    "title": "Chief Scientific Officer",    "person":     {"first_name": "Juswinder",      "last_name": "Singh",      "permalink": "juswinder-singh"}},   {"is_past": false,    "title": "VP, Chief Financial Officer",    "person":     {"first_name": "Andrew",      "last_name": "Hirsch",      "permalink": "andrew-hirsch"}}], "competitions":  [], "providerships":  [], "total_money_raised": "$4M", "funding_rounds":  [{"round_code": "unattributed",    "source_url": "http://www.masshightech.com/stories/2012/01/16/daily36-Avila-spears-4M-in-milestone-payment-from-Clovis--.html",    "source_description": "Avila spears $4M in milestone payment from Clovis ",    "raised_amount": 4000000.0,    "raised_currency_code": "USD",    "funded_year": 2012,    "funded_month": 1,    "funded_day": 20,    "investments":     [{"company":        {"name": "Clovis Oncology",         "permalink": "clovis-oncology"},       "financial_org": null,       "person": null}]}], "investments":  [], "acquisition":  {"price_amount": 925000000.0,   "price_currency_code": "USD",   "term_code": "cash",   "source_url": "http://www.reuters.com/article/2012/01/26/us-avilia-celgene-idUSTRE80P0W020120126",   "source_description": "Celgene to acquire Avila Therapeutics",   "acquired_year": 2012,   "acquired_month": 1,   "acquired_day": 26,   "acquiring_company":    {"name": "Celgene",     "permalink": "celgene"}}, "acquisitions":  [], "offices":  [{"description": "",    "address1": "100 Beaver Street ",    "address2": "",    "zip_code": "02453",    "city": "Waltham",    "state_code": "MA",    "country_code": "USA",    "latitude": null,    "longitude": null}], "milestones":  [], "ipo": null, "video_embeds":  [], "screenshots":  [{"available_sizes":     [[[150,        149],       "assets/images/resized/0014/3664/143664v1-max-150x150.jpg"],      [[250,        249],       "assets/images/resized/0014/3664/143664v1-max-250x250.jpg"],      [[450,        449],       "assets/images/resized/0014/3664/143664v1-max-450x450.jpg"]],    "attribution": null}], "external_links":  []}